Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly’s Once-Weekly Byetta Outperforms Actos, Januvia in Study
Lilly’s Once-Weekly Byetta Outperforms Actos, Januvia in Study
Lilly’s Once-Weekly Byetta Outperforms Actos, Januvia in Study
Submitted by
admin
on June 6, 2009 - 12:38pm
Source:
Bloomberg
News Tags:
Eli Lilly
Byetta
Amylin
Januvia
Merck
diabetes
Headline:
Lilly’s Once-Weekly Byetta Outperforms Actos, Januvia in Study
Do Not Allow Advertisers to Use My Personal information
